These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4310245)

  • 21. [Herpetic eye disease caused by herpes simplex virus].
    Ben-Simon G; Bareguet I
    Harefuah; 2001 Oct; 140(10):959-66. PubMed ID: 11681133
    [No Abstract]   [Full Text] [Related]  

  • 22. Activated glycyrrhizinic acid: significance against viral infections.
    Kukurtchu B
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():46-7. PubMed ID: 23236680
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intravaginal infection of mice with herpes simplex virus of 2 subtypes].
    Menarini L; Cassai EN; Corallini A; Canella C; Terni M
    Boll Ist Sieroter Milan; 1973; 52(3):201-7. PubMed ID: 4357719
    [No Abstract]   [Full Text] [Related]  

  • 25. Current therapy of herpes simplex virus infection of the cornea.
    Laibson PR
    Int Ophthalmol Clin; 1973; 13(4):39-52. PubMed ID: 4361432
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
    Levin MJ; Bacon TH; Leary JJ
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can HSV latency be conquered by current antiviral therapies?
    Simmons A; Field HJ
    Sex Transm Infect; 1998 Feb; 74(1):1-2. PubMed ID: 9634293
    [No Abstract]   [Full Text] [Related]  

  • 28. [Morbidity and mortality of mice inoculated with Herpes simplex type I and II: possible biological indicator of differentiation].
    López Bravo A; Paz J; Serrano E; Martin JM; Paino L; Valle A
    Rev Sanid Hig Publica (Madr); 1978; 52(7-8):895-901. PubMed ID: 224446
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of herpes simplex virus ribonucleotide reductase by synthetic nonapeptides: a potential antiviral therapy.
    Liuzzi M; Scouten E; Ingemarson R
    Adv Exp Med Biol; 1992; 312():129-38. PubMed ID: 1325100
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antiviral effect of human gamma globulin in mice. Comparison between local and systemic administration].
    Akerfeldt S
    Lakartidningen; 1973 Oct; 70(41):3598-9. PubMed ID: 4132634
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy of cutaneous herpesvirus infection of hairless mice.
    Lieberman M; Schafer TW; Came PE
    J Invest Dermatol; 1973 Apr; 60(4):203-6. PubMed ID: 4349225
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiviral activity of carbopol, a cross-linked polycarboxylate.
    de Clercq E; Luczak M
    Arch Virol; 1976; 52(1-2):151-8. PubMed ID: 187146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of an increase in the activity of endogenous serum DNAase-1 on the resistance of white mice to herpes simplex virus].
    Maksimovich MB; Tishechkina VA; Parfenova MS; Kartuzova VI; Bukovetskiĭ SI
    Mikrobiol Zh (1978); 1979; 41(5):542-5. PubMed ID: 530127
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiviral effect of human gamma globulin in mice. Comparison between the efficacy of local and systemic administration.
    Aherfeldt S; Löfberg E; Fuchs G
    Biochem Pharmacol; 1973 Nov; 22(22):2911-7. PubMed ID: 4128366
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of acute hepatitis B with deoxyribonuclease].
    Nikiforov ND; Mamontov SG; Il'nitskiĭ IuA; Zakharov VB; Dvurechenskaia GS; Borisov VA; Trofimova MN; Nikiforova GS; Saiapina ES; Lazutkina LI
    Sov Med; 1990; (7):82-3. PubMed ID: 2251572
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of desoxyribonuclease on herpes simplex virus].
    Kossak NI
    Mikrobiol Zh; 1967; 29(4):312-6. PubMed ID: 4310245
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiviral activity of 0-beta-D-arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice.
    Sloan BJ; Miller FA; Ehrlich J; McLean IW; Machamer HE
    Antimicrob Agents Chemother (Bethesda); 1968; 8():161-71. PubMed ID: 4309848
    [No Abstract]   [Full Text] [Related]  

  • 38. [An application of desoxyribonuclease in experimental rabies].
    Dediuk EA
    Mikrobiol Zh; 1967; 29(4):308-11. PubMed ID: 5619953
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antiviral properties of fucidin].
    Goncharskaia TIa; Navashin SM
    Antibiotiki; 1971 Jan; 16(1):57-60. PubMed ID: 4324189
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of new antiviral preparations, nuclease enzymes, in neuroviral infections].
    Lobzin VS; Sichko ZhV
    Voen Med Zh; 1973 Aug; (8):47-50. PubMed ID: 4375882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.